Ulta Lab Tests LogoContact Us

HRT for Men: Testosterone Replacement Therapy & Blood Tests

How to confirm low testosterone, weigh treatment benefits and risks, protect fertility, and plan the right laboratory follow-up.
November 12, 2026
Share with a friend:

HRT for men usually refers to testosterone replacement therapy (TRT), a prescription treatment for men with symptoms and repeatedly low testosterone levels. The decision to begin treatment depends on the cause of the deficiency, expected benefits, fertility plans, and health risks. TRT blood tests help establish a diagnosis and monitor treatment; they cannot determine the right treatment by themselves.

This guide explains what to consider before starting testosterone, which tests may help, and how newer safety and prostate-screening recommendations affect the conversation. It focuses on adult male hypogonadism. Menopausal and gender-affirming hormone therapy have different treatment goals and monitoring protocols.

For a broader view of hormone testing, prostate health, sexual symptoms, and metabolic risk, explore our Men's Health Blood Tests guide.

Hormone replacement therapy and testosterone evaluation for men.
Decisions about testosterone therapy combine symptoms, repeat laboratory testing, fertility goals, and a plan for follow-up.

HRT for Men: Key Points

  • A low laboratory result alone does not establish the need for testosterone treatment.
  • Total Testosterone is usually the first measurement. A low result generally needs confirmation on a separate morning.
  • Selected Free and Total Testosterone, SHBG, LH, FSH, and Prolactin testing may clarify the result or identify a cause.
  • TRT can suppress sperm production, so discuss future family plans before starting.
  • Benefits vary by outcome. Improved sexual desire does not guarantee improvement in fatigue, memory, weight, or erections.
  • CBC with Hemoglobin and Hematocrit, blood pressure, and appropriate PSA assessment help address treatment safety.

On this page

What Is HRT for Men?

Hormone replacement therapy is a broad term. In an adult man with hypogonadism, testosterone replacement therapy supplies testosterone that the body is not producing adequately. Testosterone helps support sexual function, muscle, bone, and red-blood-cell production.1

Testosterone can decline with age, but age alone does not diagnose hypogonadism. Problems involving the testes, pituitary gland, or hypothalamus can affect production. Obesity, sleep disorders, serious illness, and some medicines can also lower concentrations. Finding the cause helps determine whether treating an underlying problem, using testosterone, or another approach is appropriate.2, 3

Prescription options include several routes, such as injections, gels, and oral products. They differ in dosing schedules, exposure patterns, precautions, and blood-draw timing. A clinician should choose a formulation using its current label and the patient's circumstances. Products sold as testosterone boosters are not a substitute for evaluation of suspected deficiency.

How Is Low Testosterone Confirmed Before TRT?

Diagnosis combines clinical findings with repeat testing. The American Urological Association uses a Total Testosterone level below 300 ng/dL as a reasonable supporting cutoff, together with symptoms or signs and two separate early-morning measurements. This is not a universal treatment target or a reason to prescribe from one result.4

Start With Symptoms and Possible Alternative Causes

Reduced sexual desire, fewer spontaneous erections, infertility, unexplained anemia, and low bone density can prompt evaluation. Fatigue, poor concentration, low mood, and erectile dysfunction are less specific and may reflect other conditions. A symptom checklist cannot replace a medical history, examination, and appropriately selected testing.4

For a fuller symptom discussion, read Low Testosterone Symptoms: Signs, Causes, and Lab Tests. Weight-related and glucose-related contributors are covered in the Metabolic Health Blood Tests guide.

Confirm the Measurement and Investigate the Cause

  1. Obtain an appropriately timed Total Testosterone result. For diagnosis, the Endocrine Society recommends morning fasting measurements.
  2. Repeat a low result on another morning. Acute illness, sleep disruption, food intake, and medications can affect the result. Tell the clinician about these circumstances.
  3. Clarify a borderline or unexpected result. Free and Total Testosterone and SHBG may help when binding proteins make the initial result harder to interpret.
  4. Evaluate the source of the deficiency. LH and FSH help assess signaling between the brain and testes. Prolactin may be appropriate for selected patterns or symptoms.

Results must be interpreted with the assay, units, reference interval, symptoms, and prior values. See Testing Testosterone Levels: How to Get an Accurate Result for collection and interpretation details.3, 5

Which TRT Blood Tests May Be Useful?

Choose tests by the question they answer. The following blood tests cover different purposes; they are not a checklist that every person needs. A combination test may overlap with a separately ordered test, so review its contents before ordering.

Tests to Establish or Clarify the Diagnosis

TestWhat it measures and when it helpsPreparation or limitation
Testosterone Total Male Test (Adult Only)Measures total circulating testosterone. Usually the initial test for suspected deficiency and a measurement used during treatment.This product is intended for adult men. Diagnostic samples generally require morning collection and repeat confirmation when low; treatment samples follow formulation-specific timing.
Testosterone Free (Dialysis) and Total MSMeasures unbound testosterone by dialysis and total testosterone by mass spectrometry. May clarify selected borderline or discordant findings.Includes a total measurement, so a separate order may duplicate it. Free-testosterone methods and reference intervals differ.
Sex Hormone Binding Globulin TestMeasures a hormone-binding protein. Helps explain why a total measurement may not match symptoms or the unbound fraction.Weight, thyroid and liver conditions, age, and medicines can influence the result. It does not diagnose testosterone deficiency alone.14
LH TestMeasures luteinizing hormone, a pituitary signal to the testes. Helps investigate the cause of confirmed deficiency.External testosterone suppresses this signal; results during treatment do not describe untreated baseline function.
FSH TestMeasures follicle-stimulating hormone. Adds context about testicular function and reproductive signaling.Does not measure sperm count or establish fertility. Fertility requires a separate reproductive evaluation.
Prolactin TestMeasures a pituitary hormone. May help when low testosterone occurs with low or inappropriately normal pituitary signaling.Medicines, stress, and other factors can affect results. An unexpected elevation may need confirmation and further evaluation.

Tests for Baseline Assessment and Treatment Monitoring

TestClinical roleImportant limitation
Complete Blood Count with Differential and Platelets — CBC TestIncludes red cells, hemoglobin, and hematocrit. Helps identify anemia before treatment and excessive red-cell production during TRT.Dehydration, smoking, sleep apnea, and other conditions can affect results. A substantial increase requires prescriber review.
PSA Total TestMeasures prostate-specific antigen for appropriate prostate-risk assessment and follow-up.It is not cancer-specific. Enlargement, inflammation, infection, urinary retention, procedures, and medicines can affect interpretation.
Estradiol Ultrasensitive TestMeasures low estrogen concentrations. May help evaluate breast symptoms or another specific question during TRT.Not required routinely for everyone. A result alone does not establish a need for an estrogen-blocking medication.

Tests for Other Conditions That May Affect Symptoms or Risk

TestWhen it may helpImportant limitation
A1c TestEstimates average glucose exposure over roughly two to three months when diabetes or metabolic risk needs assessment.Altered red-cell turnover and some blood disorders can affect accuracy. It does not determine a TRT dose.
Lipid Panel TestMeasures cholesterol fractions and triglycerides to support cardiovascular-risk assessment.Follow the order's fasting instructions. A favorable result does not eliminate cardiovascular risk.
TSH and Free T4 TestAssesses thyroid regulation and circulating free thyroxine when thyroid disease could explain symptoms.Illness, medicines, and supplements can affect interpretation. It is not a direct measure of testosterone-treatment effectiveness.
Ferritin, Iron and Total Iron Binding Capacity PanelAssesses stored and circulating iron and iron-binding capacity when anemia, blood loss, or iron overload is a concern.Inflammation can raise ferritin. These measurements should be interpreted together and with the blood count.

These are conditional tests, not mandatory additions to every hormone order. Use the Heart Health Blood Tests guide for cardiovascular context and the CBC and Anemia Blood Tests guide for blood-count and iron evaluation.

What Benefits Can Testosterone Replacement Therapy Provide?

For appropriately diagnosed hypogonadism, treatment can improve some symptoms and consequences of deficiency. Expectations should be specific enough to review at follow-up.

OutcomeWhat the evidence supportsWhat to discuss
Sexual desire and activityThe TRAVERSE sexual-function study found improvements in desire and sexual activity in selected men with hypogonadism and low libido.Erectile function did not improve significantly in that study. Persistent erectile dysfunction may need a separate evaluation.6
AnemiaA TRAVERSE substudy found anemia corrected more often with testosterone than placebo in men with hypogonadism.Other causes of anemia still need investigation, and excessive red-cell production remains a treatment risk.7
Bone healthSome studies show improved bone density, but this does not establish fracture prevention.The TRAVERSE fracture study did not show fewer clinical fractures; more were recorded in the testosterone group. Osteoporosis needs its own care plan.8
Energy, thinking, weight, and overall functionResults are less consistent and depend on the outcome and population studied.Do not use a higher hormone result as proof that fatigue, memory, or weight concerns have been treated. Reassess persistent symptoms.2, 4

Before treatment, identify the problem you hope to improve and how progress will be assessed. If the biochemical result improves but the original symptoms do not, discuss other causes and whether continuing therapy makes sense.

What Risks and Fertility Questions Should Be Reviewed?

Discuss elevated red-cell concentration, blood pressure, fluid retention, acne, sleep apnea, urinary symptoms, cardiovascular history, and prostate history. Existing concerns may need evaluation before treatment. A clinician should review the current product label and relevant guidelines rather than infer safety from one normal laboratory result.

TRT Can Suppress Sperm Production

Testosterone supplied from outside the body can reduce the hormonal signals needed for sperm production. It can therefore worsen fertility even when sexual desire improves. The AUA/ASRM male-infertility guideline advises against prescribing external testosterone to men interested in current or future fertility.9

Discuss family-building plans before starting. Recovery after stopping varies and can take months or longer. A reproductive specialist can assess fertility and discuss appropriate alternatives; do not assume that adding another hormone will reliably preserve sperm production.

Some Findings Need Evaluation Before Treatment

Examples include unexplained PSA elevation or a prostate abnormality, elevated hematocrit, untreated severe sleep apnea, severe urinary symptoms, or unstable cardiovascular illness. Prior prostate cancer requires a specialist discussion. These situations cannot be resolved by ordering a larger hormone panel.3, 4

What Changed in Testosterone Safety and Prostate-Screening Guidance?

FDA Labeling Changes Require Careful Interpretation

In February 2025, FDA requested removal of boxed-warning language about increased major cardiovascular outcomes after reviewing TRAVERSE. It also required warnings about increased blood pressure. In June 2026, FDA requested further revisions involving the age-related limitation-of-use statement and prostate-cancer and benign prostatic hyperplasia safety information.10, 11

TRAVERSE studied monitored testosterone-gel treatment in men ages 45–80 with confirmed hypogonadism and cardiovascular disease or elevated cardiovascular risk. Rates of major cardiovascular events were similar between groups, but atrial fibrillation, acute kidney injury, and pulmonary embolism were reported more often with testosterone. The results do not establish safety for every formulation, dose, patient, or duration.12

The Endocrine Society's July 2026 statement continued to emphasize accurate diagnosis, individualized prescribing, and follow-up. It also noted unresolved long-term safety questions and emphasized addressing reversible contributors such as excess weight and medication effects. Labeling changes do not make TRT a general anti-aging or weight-loss treatment.2

The November 2026 ACS Screening Update Is Separate From TRT Monitoring

After an informed discussion of benefits, limitations, and potential harms, the American Cancer Society recommends PSA screening every 2 years for average-risk men ages 50–69 and annually for Black men ages 45–69. For non-Black men ages 45–69, annual screening applies when a father, brother, or son was diagnosed before 65, or more than one of these relatives has had prostate cancer. With one such relative diagnosed at 65 or older, the interval is every 2 years.13

Older ages, inherited risk, and life expectancy need individualized review. See PSA Levels Explained for the full schedule and follow-up pathway.

Before TRT, AUA guidance recommends PSA testing in men older than 40. During the first treatment year, the Endocrine Society recommends urological consultation for a confirmed PSA increase greater than 1.4 ng/mL above baseline, a confirmed PSA above 4.0 ng/mL, or an abnormal prostate examination. These treatment criteria do not replace the ACS screening confirmation threshold of 3.0 ng/mL for men younger than 70.3, 4, 13

A routine screening interval should not delay evaluation of a new symptom, an unexpected result, or a treatment-related change.

How Are TRT Blood Tests Scheduled and Prepared?

The Endocrine Society guideline describes reassessment of Total Testosterone and hematocrit at approximately 3–6 months, at 12 months, and annually thereafter. Product-specific requirements, treatment changes, or unexpected findings may require a different schedule. PSA follow-up is individualized, with prostate-risk reassessment commonly occurring within 3–12 months for those choosing monitoring.5

A hematocrit above 54% requires prompt prescriber review under that guideline; the clinician may interrupt or adjust treatment and investigate contributing causes. Do not manage the result by changing your dose or arranging repeated blood donation on your own.

  • Document the dose and formulation. Include the date and time of the last dose and blood draw.
  • Follow the correct collection window. Diagnostic morning sampling and treatment-monitoring timing answer different questions.
  • Follow fasting instructions. Requirements depend on the ordered tests and the clinician's plan.
  • Report medicines, supplements, illness, and disrupted sleep. Do not stop prescribed medicines without instructions.
  • Compare like with like. Similar timing and methods make trends easier to interpret.

Use the HRT and TRT Monitoring guide for detailed follow-up questions and the Testing Testosterone Levels guide for collection and interpretation.

When Should You Seek Care Instead of Ordering More Tests?

Seek emergency care for chest pain, sudden severe shortness of breath, stroke symptoms, or other rapidly worsening illness. Complete urinary retention needs urgent assessment. Report new breast changes, substantial urinary changes, persistent swelling, severe headaches, or treatment-related concerns promptly to the prescribing clinician. Direct-access testing should not delay care.

How Ulta Lab Tests Can Support a Clinician-Directed Plan

Ulta Lab Tests provides access to relevant blood tests where available. Use the product pages above to review the specimen, preparation requirements, included measurements, and current ordering information. Select the tests that match the question being investigated, then share the results with the clinician responsible for diagnosis or treatment.

A lab order does not provide a testosterone prescription, determine a dose, or replace a physical examination. Before ordering, decide what an unexpected result would change and who will help interpret it.

Frequently Asked Questions About HRT for Men

Is HRT for men the same as TRT?

In many men's-health discussions, HRT refers to TRT. The broader term can cover other hormone treatments, so clarify the medication and diagnosis being discussed.

Can one low result show that I need testosterone therapy?

No. An appropriately timed Total Testosterone result usually needs confirmation on another morning, together with symptoms, history, and evaluation of the cause. A result obtained during illness or under different collection conditions may not reflect a persistent disorder.

Does everyone need Free and Total Testosterone and SHBG?

No. These tests are most useful when the initial measurement is borderline, binding proteins may be altered, or findings do not fit the clinical picture. Avoid ordering overlapping measurements without a reason.

Can TRT improve erections and energy?

Some men experience improvements, particularly in sexual desire, but responses vary. Erectile dysfunction and fatigue often have other causes. Treatment should be judged against the original goals, not simply a higher laboratory number.

Can I use TRT while trying to have children?

External testosterone can suppress sperm production. Discuss fertility before starting and seek reproductive evaluation when needed. Improved libido does not establish normal fertility.

Do the FDA updates mean TRT has no cardiovascular risk?

No. The updated evidence addresses particular outcomes in a defined population. Blood pressure and other adverse effects still matter, and treatment needs individual assessment and follow-up.

Does an elevated PSA result mean cancer?

No. Benign prostate conditions and other factors can affect the result. Confirmation and clinical assessment may be needed; a blood result does not establish a prostate-cancer diagnosis.

Should I order the largest hormone panel?

Choose a panel only when its components fit the clinical question. More measurements can create duplicate tests or findings that are difficult to interpret. A focused order is often easier to connect to a clear follow-up plan.

References

  1. MedlinePlus: Testosterone Levels Test.
  2. Endocrine Society: Statement on Testosterone Replacement Therapy. July 16, 2026.
  3. Endocrine Society: Testosterone Therapy for Hypogonadism Guideline Resources.
  4. American Urological Association: Evaluation and Management of Testosterone Deficiency.
  5. Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. 2018.
  6. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men With Hypogonadism.
  7. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism. 2023.
  8. Testosterone Treatment and Fractures in Men With Hypogonadism. 2024.
  9. AUA/ASRM: Diagnosis and Treatment of Infertility in Men. Amended 2024.
  10. FDA: Class-Wide Labeling Changes for Testosterone Products. February 2025.
  11. FDA: Testosterone Information and June 2026 Requested Labeling Updates.
  12. Cardiovascular Safety of Testosterone-Replacement Therapy. 2023.
  13. American Cancer Society: Guideline for Prostate Cancer Early Detection. November 12, 2026.
  14. MedlinePlus: SHBG Blood Test.

Updated: November 12, 2026.

Medical and commercial disclosure: Ulta Lab Tests offers laboratory-testing services. This article is educational and does not provide an individual diagnosis or treatment plan. Review results and treatment decisions with a qualified healthcare professional. Do not start, stop, or change prescribed hormone therapy based only on this article or one test result.

Recommended Lab Tests

Share with a friend: 
Copyright © 2013-2026 Ulta Lab Tests, LLC All Rights Reserved.